P. Vanderheyden

发表

Clozapine, atypical antipsychotics, and the benefits of fast-off D2 dopamine receptor antagonism

P. Seeman, G. Vauquelin, Sophie Bostoen, 2012, Naunyn-Schmiedeberg's Archives of Pharmacology.

Effect of BIBP3226 on inositol phosphate accumulation and cytosolic calcium level in control and NPY Y1 receptor expressing CHO-K1 cells

G. Vauquelin, G. Ebinger, P. Vanderheyden, 1998, Regulatory Peptides.

[3H]-BIBP3226 and [3H]-NPY binding to intact SK-N-MC cells and CHO cells expressing the human Y1 receptor.

G. Vauquelin, P. Vanderheyden, I. Van Liefde, 1998, Journal of receptor and signal transduction research.

Distinct binding properties of the AT(1) receptor antagonist [(3)H]candesartan to intact cells and membrane preparations.

G. Vauquelin, P. Vanderheyden, J. De Backer, 2002, Biochemical pharmacology.

AT1 Receptor Interactions

G. Vauquelin, P. Vanderheyden, 2004 .

New insights in insurmountable antagonism

G. Vauquelin, P. Vanderheyden, I. Van Liefde, 2002, Fundamental & clinical pharmacology.

Models and methods for studying insurmountable antagonism.

G. Vauquelin, P. Vanderheyden, I. Van Liefde, 2002, Trends in pharmacological sciences.

Subtypes of adrenergic and dopaminergic receptors in bovine cerebral blood vessels

G. Vauquelin, A. Convents, J. Keyser, 1988, Neuroscience Letters.

Beta-homo-amino acid scan of angiotensin IV.

P. Karoyan, A. Misicka, G. Vauquelin, 2008, Journal of medicinal chemistry.

EFFECTS OF BIBP3226 AND BIBP3435 ON CYTOSOLIC CALCIUM IN NEUROPEPTIDE Y Y1 RECEPTOR-TRANSFECTED CHINESE HAMSTER OVARY CELLS AND WILD TYPE CHO-K1 CELLS

G. Vauquelin, G. Ebinger, P. Vanderheyden, 2001, Journal of receptor and signal transduction research.

Interaction between the partially insurmountable antagonist valsartan and human recombinant angiotensin II type 1 receptors

G. Vauquelin, P. Vanderheyden, J. Debacker, 2000, Fundamental & clinical pharmacology.

Conformational constraints in angiotensin IV to probe the role of Tyr2, Pro5 and Phe6

G. Vauquelin, D. Tourwé, P. Vanderheyden, 2011, Journal of peptide science : an official publication of the European Peptide Society.

Cellular targets for angiotensin II fragments: pharmacological and molecular evidence

Y. Michotte, G. Vauquelin, I. Smolders, 2002, Journal of the renin-angiotensin-aldosterone system : JRAAS.

Distinction between surmountable and insurmountable selective AT1 receptor antagonists by use of CHO‐K1 cells expressing human angiotensin II AT1 receptors

G. Vauquelin, P. Vanderheyden, J. De Backer, 1999, British journal of pharmacology.

Agonist induction and conformational selection during activation of a G-protein-coupled receptor.

L. Hunyady, G. Vauquelin, P. Vanderheyden, 2003, Trends in pharmacological sciences.

Angiotensin IV Is a Potent Agonist for Constitutive Active Human AT1 Receptors

L. Hunyady, G. Vauquelin, P. Vanderheyden, 2002, The Journal of Biological Chemistry.

Translocation of the insulin‐regulated aminopeptidase to the cell surface: detection by radioligand binding

Y. Michotte, G. Vauquelin, P. Vanderheyden, 2008, British journal of pharmacology.

Involvement of insulin-regulated aminopeptidase in the effects of the renin–angiotensin fragment angiotensin IV: a review

Y. Michotte, G. Vauquelin, I. Smolders, 2008, Heart Failure Reviews.

Class A Orphans in GtoPdb v.2021.3

Stephen P. H. Alexander, Wen Chiy Liew, Leigh A. Stoddart, 2021, IUPHAR/BPS Guide to Pharmacology CITE.

Synergistic modulation of cystinyl aminopeptidase by divalent cation chelators.

Y. Michotte, V. Kersemans, G. Vauquelin, 2004, Biochemical pharmacology.

Antidepressant-like effects of oxytocin in mice are dependent on the presence of insulin-regulated aminopeptidase.

Y. Michotte, I. Smolders, P. Gard, 2013, The international journal of neuropsychopharmacology.

Image mean square displacement to study the lateral mobility of Angiotensin II type 1 and Endothelin 1 type A receptors on living cells

C. Caballero-George, E. Gratton, P. Vanderheyden, 2019, Microscopy research and technique.

A two-state receptor model for the interaction between angiotensin II type 1 receptors and non-peptide antagonists.

G. Vauquelin, P. Morsing, P. Vanderheyden, 2001, Biochemical pharmacology.

The role of the central renin-angiotensin system in Parkinson’s disease

Y. Michotte, P. Vanderheyden, S. Sarre, 2010, Journal of the renin-angiotensin-aldosterone system : JRAAS.

Muscarinic acetylcholine receptors.

J. Hoebeke, J. Guillet, P. Vanderheyden, 1979 .

Direct angiotensin II type 2 receptor stimulation decreases dopamine synthesis in the rat striatum

Y. Michotte, P. Vanderheyden, S. Sarre, 2010, Neuropharmacology.

Reversible and syntopic interaction between angiotensin receptor antagonists on Chinese hamster ovary cells expressing human angiotensin II type 1 receptors.

G. Vauquelin, P. Vanderheyden, J. De Backer, 2000, Biochemical pharmacology.

Angiotensin II type 1 receptor antagonists. Why do some of them produce insurmountable inhibition?

G. Vauquelin, P. Vanderheyden, F. Fierens, 2000, Biochemical pharmacology.

Effect of maturation and aging on beta-adrenergic signal transduction in rat kidney and liver.

J. Vandekerckhove, J. van Emmelo, Ariane Bazan, 2000, Biochemical pharmacology.

AT1 Receptor Ligands: Virtual‐Screening‐Based Design with TOPP Descriptors, Synthesis, and Biological Evaluation of Pyrrolidine Derivatives

K. Watson, M. Sinicropi, A. Catalano, 2007, ChemMedChem.

Insurmountable AT(1) receptor antagonism: the need for different antagonist binding states of the receptor.

G. Vauquelin, P. Vanderheyden, F. Fierens, 2001, Trends in pharmacological sciences.

Insurmountable angiotensin AT1 receptor antagonists: the role of tight antagonist binding.

G. Vauquelin, P. Vanderheyden, J. De Backer, 1999, European journal of pharmacology.

Monoclonal antibodies against the native or denatured forms of muscarinic acetylcholine receptors.

A. Strosberg, J. Hoebeke, J. Guillet, 1984, The EMBO journal.

Brain and peripheral angiotensin II type 1 receptors mediate renal vasoconstrictor and blood pressure responses to angiotensin IV in the rat

A. Dupont, I. Smolders, D. De Bundel, 2008, Journal of hypertension.

G-Protein–Coupled Receptor Mas Is a Physiological Antagonist of the Angiotensin II Type 1 Receptor

P. Sexton, A. Christopoulos, T. Walther, 2005, Circulation.

Number and brightness analysis to study spatio-temporal distribution of the angiotensin II AT1 and the endothelin-1 ETA receptors: Influence of ligand binding.

C. Caballero-George, E. Gratton, M. Digman, 2019, Biochimica et biophysica acta. General subjects.

Influence of the cellular environment on ligand binding kinetics at membrane-bound targets.

P. Vanderheyden, Nerdjes Benachour, 2017, Bioorganic & medicinal chemistry letters.

Trans-Modulation of the Somatostatin Type 2A Receptor Trafficking by Insulin-Regulated Aminopeptidase Decreases Limbic Seizures

G. Collingridge, P. Gressens, S. Peineau, 2015, The Journal of Neuroscience.

Formation of angiotensin-(1–7) from angiotensin II by the venom of Conus geographus

J. Broeck, G. Baggerman, G. Vauquelin, 2002, Regulatory Peptides.

Genomic organisation and functional expression of the gene encoding the human serotonin 5-HT2C receptor.

T. de Boer, W. Olijve, P. Vanderheyden, 1994, European journal of pharmacology.

Design, Synthesis, and Biological Evaluation of Bivalent Ligands Targeting Dopamine D2‐Like Receptors and the μ‐Opioid Receptor

S. van Calenbergh, C. Stove, P. Vanderheyden, 2018, ChemMedChem.

[3H]IVDE77, a novel radioligand with high affinity and selectivity for the insulin-regulated aminopeptidase.

J. V. Van Ginderachter, G. Vauquelin, D. Tourwé, 2013, European Journal of Pharmacology.

Pressor and Renal Hemodynamic Effects of the Novel Angiotensin A Peptide Are Angiotensin II Type 1A Receptor Dependent

A. Dupont, T. Walther, G. Vauquelin, 2011, Hypertension.

Renin-Angiotensin-Aldosterone System Pressor and Renal Hemodynamic Effects of the Novel Angiotensin A Peptide Are Angiotensin II Type 1 A Receptor Dependent

A. Dupont, T. Walther, G. Vauquelin, 2011 .

Involvement of insulin-regulated aminopeptidase and/or aminopeptidase N in the angiotensin IV-induced effect on dopamine release in the striatum of the rat

Y. Michotte, G. Vauquelin, I. Smolders, 2007, Brain Research.

Peptide and nonpeptide antagonist interaction with constitutively active human AT1 receptors.

L. Hunyady, V. Kersemans, G. Vauquelin, 2003, Biochemical pharmacology.

In vitro effect of sanguinarine alkaloid on binding of [3H]candesartan to the human angiotensin AT1 receptor.

Mahabir P. Gupta, C. Caballero-George, G. Vauquelin, 2003, European journal of pharmacology.

Tight binding of the angiotensin AT1 receptor antagonist [3H]candesartan is independent of receptor internalization

G. Vauquelin, P. Vanderheyden, T. Thekkumkara, 2001 .

Role of basic amino acids of the human angiotensin type 1 receptor in the binding of the non-peptide antagonist candesartan

L. Hunyady, G. Vauquelin, P. Vanderheyden, 2001, Journal of the renin-angiotensin-aldosterone system : JRAAS.

Effect of saponin and filipin on antagonist binding to AT 1 receptors in intact cells.

Dieter M. Tourlousse, G. Vauquelin, P. Vanderheyden, 2004, Biochemical pharmacology.

Deletion of insulin-regulated aminopeptidase in mice decreases susceptibility to pentylenetetrazol-induced generalized seizures

Y. Michotte, I. Smolders, P. Vanderheyden, 2011, Seizure.

Angiotensin IV Activates the Nuclear Transcription Factor-&kgr;B and Related Proinflammatory Genes in Vascular Smooth Muscle Cells

J. Egido, M. Ruíz-Ortega, Ó. Lorenzo, 2005, Circulation research.

Ligand binding and functional properties of human angiotensin AT1 receptors in transiently and stably expressed CHO-K1 cells.

L. Hunyady, G. Vauquelin, P. Vanderheyden, 2005, European journal of pharmacology.

Metabolism of angiotensin II is required for its in vivo effect on dopamine release in the striatum of the rat

Y. Michotte, G. Vauquelin, G. Ebinger, 2004, Journal of neurochemistry.

Molecular characterization of the high‐affinity [3H]neuropeptide Y‐binding component from the venom of Conus anemone

G. Vauquelin, P. Vanderheyden, F. Fierens, 2003, Fundamental & clinical pharmacology.

Presence and regulation of insulin-regulated aminopeptidase in mouse macrophages

J. V. Van Ginderachter, D. Laoui, D. Tourwé, 2014, Journal of the renin-angiotensin-aldosterone system : JRAAS.

Biological screening of selected medicinal Panamanian plants by radioligand-binding techniques.

C. Caballero-George, G. Vauquelin, L. Pieters, 2001, Phytomedicine : international journal of phytotherapy and phytopharmacology.

High affinity displacement of [(3)H]NPY binding to the crude venom of conus anemone by insect neuropeptides.

J. Broeck, P. Vanderheyden, J. De Backer, 1999, Biochemical and biophysical research communications.

Distinctions between non-peptide angiotensin II AT1-receptor antagonists

G. Vauquelin, P. Vanderheyden, F. Fierens, 2001, Journal of the renin-angiotensin-aldosterone system : JRAAS.

Different agonist binding properties of M1 and M2 muscarinic receptors in calf brain cortex membranes.

G. Vauquelin, G. Ebinger, P. Vanderheyden, 1987, Biochemical pharmacology.

Complex FFA1 receptor (in)dependent modulation of calcium signaling by free fatty acids.

P. Vanderheyden, S. Engelbeen, Ilektra Petrina Katsouri, 2022, Biochemical pharmacology.

G-Protein–Coupled Receptor Mas Is a Physiological Antagonist of the Angiotensin II Type 1 Receptor Molecular Cardiology

P. Sexton, A. Christopoulos, G. Milligan, 2005 .

Non-competitive binding of the nonpeptide antagonist BIBP3226 to rat forebrain neuropeptide Y1 receptors.

G. Vauquelin, P. Vanderheyden, I. Van Liefde, 1997, European journal of pharmacology.

Molecular distinction between calf heart and brain muscarine receptors: different N-ethylmaleimide modulation of agonist binding.

G. Vauquelin, P. Vanderheyden, L. Kanarek, 1986, European Journal of Pharmacology.

Effects of Chronic Antidepressant Treatment on the Hypothalamic‐Pituitary‐Adrenal Axis of Wistar Rats

P. Vanderheyden, B. Peeters, R. Heijden, 1994 .

Characterization of muscarinic receptors in human, guinea pig and rat lung.

G. Pauli, C. Bertrand, J. Gies, 1989, The Journal of pharmacology and experimental therapeutics.

Synergistic inhibition of the enzymatic activity of aminopeptidase N by divalent metal ion chelators

G. Vauquelin, P. Vanderheyden, L. Vogel, 2006, Fundamental & clinical pharmacology.

THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors

Stephen P. H. Alexander, Leigh A. Stoddart, Kalyan C. Tirupula, 2021, British journal of pharmacology.

From angiotensin IV binding site to AT4 receptor

P. Vanderheyden, 2009, Molecular and Cellular Endocrinology.

Phylogenetic Diversity of Sponge-Associated Fungi from the Caribbean and the Pacific of Panama and Their In Vitro Effect on Angiotensin and Endothelin Receptors

C. Caballero-George, A. Miller, H. Raja, 2015, Marine Biotechnology.

Epinephrine and norepinephrine stimulation of adenylate cyclase in bovine retina homogenate: evidence for interaction with the dopamine D1 receptor.

G. Vauquelin, G. Ebinger, P. Vanderheyden, 1986, Life sciences.

Amino triazolo diazepines (Ata) as constrained histidine mimics.

G. Vauquelin, D. Tourwé, P. Vanderheyden, 2011, Organic letters.

Endogenous cystinyl aminopeptidase in Chinese hamster ovary cells: characterization by [125I]Ang IV binding and catalytic activity.

Veerle Kersemans, Minh Tam Le, Patrick Vanderheyden, 2004, Biochemical pharmacology.

Inhibitory Activity on Binding of Specific Ligands to the Human Angiotensin II AT1 and Endothelin 1 ETA Receptors: Bioactive Benzo[c]phenanthridine Alkaloids from the Root of Bocconia frutescens

C. Caballero-George, M. Claeys, S. Apers, 2002, Planta medica.

Evaluation of bioactive saponins and triterpenoidal aglycons for their binding properties on human endothelin ETA and angiotensin AT1 receptors

Mahabir P. Gupta, C. Caballero-George, T. Masaki, 2004, Phytotherapy research : PTR.

Class A Orphans (version 2019.5) in the IUPHAR/BPS Guide to Pharmacology Database

Adam J Pawson, Stephen P. H. Alexander, Wen Chiy Liew, 2019, IUPHAR/BPS Guide to Pharmacology CITE.

Angiotensin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

Kalyan C. Tirupula, L. Hunyady, P. Timmermans, 2019, IUPHAR/BPS Guide to Pharmacology CITE.

Short ReviewGlucocorticoid Receptor Antagonists: New Tools to Investigate Disorders Characterized by Cortisol Hypersecretion

G. Ruigt, P. Vanderheyden, W. Schoonen, 2004, Stress.

Human M1-, M2- and M3-muscarinic cholinergic receptors: Binding characteristics of agonists and antagonists

Patrick Vanderheyden, J. Gies, G. Vauquelin, 1990, Journal of the Neurological Sciences.

Characterization of M1- and M2-muscarinic receptors in calf retina membranes

G. Vauquelin, G. Ebinger, P. Vanderheyden, 1988, Vision Research.

Muscarinic cholinergic receptor subtypes in normal human brain and Alzheimer's presenile dementia

G. Vauquelin, G. Vauquelin, R. Dierckx, 1987, Journal of the Neurological Sciences.

International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli

Kalyan C. Tirupula, S. Karnik, S. Eguchi, 2015, Pharmacological Reviews.

Human neuropeptide YY1 receptors exert unequal control of the extracellular acidification rate in different cell lines.

G. Vauquelin, P. Vanderheyden, I. Van Liefde, 1998, European journal of pharmacology.

Class A Orphans (version 2020.5) in the IUPHAR/BPS Guide to Pharmacology Database

Helen E. Benson, Michael Spedding, Richard R. Neubig, 2020 .

Differential muscarinic receptor binding of acetylcholinesterase inhibitors in rat brain, human brain and Chinese hamster ovary cells expressing human receptors.

G. Vauquelin, M. Oortgiesen, P. Vanderheyden, 1997, The Journal of pharmacology and experimental therapeutics.

The Type of Fat in the Diet Influences the Behavior and the Relationship Between Cystinyl and Alanyl Aminopeptidase Activities in Frontal Cortex, Liver, and Plasma

Š. Zórad, P. Vanderheyden, M. de Gasparo, 2020, Frontiers in Molecular Biosciences.

Radiolabelling of the human 5-HT2A receptor with an agonist, a partial agonist and an antagonist: effects on apparent agonist affinities.

A. Sleight, V. Mutel, P. Vanderheyden, 1996, Biochemical pharmacology.

Combined in situ hybridisation, northern blot analysis, and receptor binding studies in clones expressing different levels of the human 5-HT1A receptor.

M. Shahid, G. Ruigt, P. Vanderheyden, 1995, Journal of receptor and signal transduction research.

Use of a Cloned G-Protein-coupled Receptor in the In Vitro Screening of Psychotropic Compounds

P. Vanderheyden, N. Stam, G. Ruigt, 1993 .

Agonist mediated conformational changes of solubilized calf forebrain muscarinic acetylcholine receptors.

G. Vauquelin, P. Vanderheyden, J. De Backer, 1984, Biochemical pharmacology.

The venom of Conus pennaceus inhibits the binding of [3H]neuropeptide Y by direct interaction with the radioligand

G. Vauquelin, P. Vanderheyden, B. Diallo, 1998, Neurochemistry International.

NEUROPEPTIDE Y RECEPTORS FROM CALF BRAIN: EFFECT OF CRUDE CONUS VENOM PREPARATIONS ON [3H]NPY BINDING

G. Vauquelin, P. Vanderheyden, E. Czerwiec, 1996, Neurochemistry International.

High-affinity binding of [3H]neuropeptide Y to a polypeptide from the venom of Conus anemone.

G. Vauquelin, P. Vanderheyden, E. Czerwiec, 1996, European journal of pharmacology.

Identification of M2 muscarinic receptors in membranes from bovine cerebral basal arteries.

G. Vauquelin, G. Ebinger, P. Vanderheyden, 1986, Life sciences.

Purification of muscarinic acetylcholine receptors by affinity chromatography.

A. Strosberg, G. Vauquelin, P. Vanderheyden, 1983, The EMBO journal.

Modulation of Calcium Signaling of Angiotensin AT1, Endothelin ETA, and ETB Receptors by Silibinin, Quercetin, Crocin, Diallyl Sulfides, and Ginsenoside Rb1

C. Caballero-George, P. Vanderheyden, Anja Hoffmann, 2014, Planta Medica.

Changes in prepulse inhibition after local administration of NMDA receptor ligands in the core region of the rat nucleus accumbens.

L. Reijmers, P. Vanderheyden, B. Peeters, 1995, European journal of pharmacology.

Mimicking of Arginine by Functionalized N(ω)-Carbamoylated Arginine As a New Broadly Applicable Approach to Labeled Bioactive Peptides: High Affinity Angiotensin, Neuropeptide Y, Neuropeptide FF, and Neurotensin Receptor Ligands As Examples.

J. Svobodová, M. Keller, A. Buschauer, 2016, Journal of medicinal chemistry.

Tissue distribution of CysAP activity and its relationship to blood pressure and water balance.

F. Vives, Š. Zórad, P. Vanderheyden, 2015, Life sciences.

Ang II and Ang IV: Unraveling the Mechanism of Action on Synaptic Plasticity, Memory, and Epilepsy

Y. Michotte, I. Smolders, P. Vanderheyden, 2008, CNS neuroscience & therapeutics.

Involvement of the AT1 receptor subtype in the effects of angiotensin IV and LVV‐haemorphin 7 on hippocampal neurotransmitter levels and spatial working memory

Y. Michotte, G. Vauquelin, V. Caveliers, 2010, Journal of neurochemistry.

Renal vasoconstrictor and pressor responses to angiotensin IV in mice are AT1a-receptor mediated

A. Dupont, T. Walther, I. Smolders, 2009, Journal of hypertension.

Clozapine, atypical antipsychotics, and the benefits of fast-off D2 dopamine receptor antagonism

P. Seeman, G. Vauquelin, Sophie Bostoen, 2012, Naunyn-Schmiedeberg's Archives of Pharmacology.

Antagonist-radioligand binding to D2L-receptors in intact cells.

G. Vauquelin, P. Vanderheyden, A. Packeu, 2008, Biochemical pharmacology.

Angiotensin receptors in GtoPdb v.2023.1 Angiotensin receptors in GtoPdb v.2023.1

Kalyan C. Tirupula, L. Hunyady, K. Catt, 2023 .

IRAP and AT1 receptor mediated effects of angiotensin IV

P. Vanderheyden, I. Smolders, A. Dupont, 2009, Journal of internal medicine.

Inhibition of Angiotensin II-Induced Inositol Phosphate Production by Triacid Nonpeptide Antagonists in CHO Cells Expressing Human AT1 Receptors

G. Vauquelin, P. Vanderheyden, F. Fierens, 2000, Pharmaceutical Research.

Binding characteristics of [3H]-irbesartan to human recombinant angiotensin type 1 receptors

G. Vauquelin, P. Vanderheyden, J. De Backer, 2000, Journal of the renin-angiotensin-aldosterone system : JRAAS.

Binding of the antagonist [3H]candesartan to angiotensin II AT1 receptor-transfected [correction of tranfected] Chinese hamster ovary cells.

G. Vauquelin, P. Vanderheyden, J. De Backer, 1999, European journal of pharmacology.

In vitro inhibition of [3H]-angiotensin II binding on the human AT1 receptor by proanthocyanidins from Guazuma ulmifolia bark.

Mahabir P. Gupta, C. Caballero-George, M. Claeys, 2002, Planta medica.

Dual effect of N-ethylmaleimide on agonist binding to bovine heart muscarinic receptors.

G. Vauquelin, G. Ebinger, P. Vanderheyden, 1990, Archives internationales de pharmacodynamie et de therapie.

Angiotensin AT4 receptor ligand interaction with cystinyl aminopeptidase and aminopeptidase N: [125I]Angiotensin IV only binds to the cystinyl aminopeptidase apo-enzyme.

Minh Tam Le, Patrick Vanderheyden, Yvette Michotte, 2006, European journal of pharmacology.

Metal ion modulation of cystinyl aminopeptidase.

Y. Michotte, V. Kersemans, G. Vauquelin, 2005, The Biochemical journal.

Lys 199 mutation of the human angiotensin type 1 receptor differentially affects the binding of surmountable and insurmountable non-peptide antagonists

A. IJzerman, L. Hunyady, G. Vauquelin, 2000, Journal of the renin-angiotensin-aldosterone system : JRAAS.

D1 dopamine receptors in human putamen, frontal cortex and calf retina: differences in guanine nucleotide regulation of agonist binding and adenylate cyclase stimulation

G. Vauquelin, R. Dierckx, J. Keyser, 1988, Brain Research.

System Journal of Renin-angiotensin-aldosterone Journal of Renin-angiotensin-aldosterone System the Role of the Central Renin-angiotensin System in Parkinson's Disease Journal of Renin-angiotensin-aldosterone System Additional Services and Information For

Y. Michotte, P. Vanderheyden, S. Sarre, 2022 .

AT1 receptor antagonists.

G. Vauquelin, P. Vanderheyden, J. De Backer, 2004, Current Medicinal Chemistry - Cardiovascular & Hematological Agents.

The replacement of His(4) in angiotensin IV by conformationally constrained residues provides highly potent and selective analogues.

G. Vauquelin, D. Tourwé, P. Vanderheyden, 2009, Journal of medicinal chemistry.

Binding of the antagonist []candesartan to angiotensin II AT1 receptor-tranfected Chinese hamster ovary cells

G. Vauquelin, P. Vanderheyden, F. Fierens, 1999 .

Tight binding of the angiotensin AT(1) receptor antagonist.

G. Vauquelin, P. Vanderheyden, T. Thekkumkara, 2001, Biochemical Pharmacology.

A two-state model of antagonist-AT1 receptor interaction: further support by binding studies at low temperature.

G. Vauquelin, P. Vanderheyden, J. De Backer, 2003, Biochemical pharmacology.

Ang II and Ang IV: Unraveling the Mechanism of Action on Synaptic Plasticity, Memory, and Epilepsy

Y. Michotte, I. Smolders, P. Vanderheyden, 2008, CNS neuroscience & therapeutics.

Phylogenetic Diversity of Sponge-Associated Fungi from the Caribbean and the Pacific of Panama and Their In Vitro Effect on Angiotensin and Endothelin Receptors

C. Caballero-George, A. Miller, H. Raja, 2015, Marine Biotechnology.

Presence and regulation of insulin-regulated aminopeptidase in mouse macrophages

J. V. Van Ginderachter, D. Tourwé, B. Stijlemans, 2014, Journal of the renin-angiotensin-aldosterone system : JRAAS.